TY  - JOUR
AU  - Aterido, Adria
AU  - Cañete, Juan D
AU  - Tornero, Jesus
AU  - Blanco, Francisco
AU  - Fernandez-Gutierrez, Benjamin
AU  - Perez, Carolina
AU  - Alperi-Lopez, Mercedes
AU  - Olive, Alex
AU  - Corominas, Hector
AU  - Martinez-Taboada, Victor
AU  - Gonzalez, Isidoro
AU  - Fernandez-Nebro, Antonio
AU  - Erra, Alba
AU  - Lopez-Lasanta, Maria
AU  - Lopez-Corbeto, Mireia
AU  - Palau, Núria
AU  - Marsal, Sara
AU  - Julia, Antonio
PY  - 2019
DO  - 10.3389/fimmu.2019.01459
UR  - http://hdl.handle.net/10668/14246
T2  - Frontiers in immunology
AB  - Background: Rheumatoid arthritis (RA) is the most frequent autoimmune disease involving the joints. Although anti-TNF therapies have proven effective in the management of RA, approximately one third of patients do not show a significant clinical...
LA  - en
PB  - Frontiers Research Foundation
KW  - Anti-TNF therapy
KW  - Genomics
KW  - Multi-omics association analysis
KW  - Rheumatoid arthritis
KW  - Transcriptomics
KW  - Adalimumab
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - Biopsy
KW  - Cohort Studies
KW  - Female
KW  - Gene Regulatory Networks
KW  - Genome-Wide Association Study
KW  - Humans
KW  - Infliximab
KW  - Male
KW  - Polymorphism, Single Nucleotide
KW  - Synovial Membrane
KW  - Transcriptome
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
TI  - A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
TY  - research article
VL  - 10
ER  -